Asia · General news · New Straits Times
Johnson & Johnson looking to buy Ollin Biosciences for up to US$3.4bil
Detailed summary
Johnson & Johnson is poised to buy privately held eye disease drug developer Ollin Biosciences for up to US$3.4 billion, the Financial Times reported on Sunday, citing people…
MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.nst.com.my)




